QIAGEN (QGENF) - Star of Germany's Biotechs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (54)	3/20/1998 10:42:00 AM
From: Andreas Helke	Read Replies (1) of 122

I think the major problem is that too much money is chasing too few stocks. The Neue Markt is pretty new and was intended to be a place where innovative small companies could get a listing with less strict requierements than on germanys big boards. If you got into one of the later IPOs it was a shure double over night. I assume that some of the early IPOs were priced too low and now people see how much money they could have made if they had bought those companies early. 1996 we had no good place for innovative growth companies. Therefore Qiagen and Pfeiffer Vacuum decided that they would avoid the german market and do their IPO on the NASDAQ. Now Qiagen is already listed on the Neue Markt and Pfeiffer intends to get there too. That we have a serious bull market helps of course. Even the DAX with the 30 biggest companies went up 50% last year. The Neue Markt already doubled this year. Andreas

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next